The Major Histocompatibility Complex (MHC) Molecules: Definition and Core Function
The Major Histocompatibility Complex (MHC) is a highly specialized, tightly linked cluster of genes located on chromosome 6 in humans, where it is referred to as the Human Leukocyte Antigen (HLA) system. The primary function of the MHC-encoded molecules is to serve as the critical bridge between the innate and adaptive immune systems. These cell surface glycoproteins are essentially specialized display pedestals: their sole physiological role is to bind small peptide fragments derived from intracellular or extracellular proteins and present them on the cell surface for scrutiny by T lymphocytes (T cells).
This process of antigen presentation is fundamental to immune surveillance. In a healthy cell, MHC molecules present “self-peptides,” which T cells are trained to ignore. In a cell infected by a virus or that has become malignant, the MHC molecule will present a “non-self” or foreign peptide, which is instantly recognized by the appropriate T cell, triggering an immune response to eliminate the threat. The term “histocompatibility,” meaning “tissue compatibility,” originates from the molecules’ initial discovery as the primary antigens responsible for the rejection of transplanted organs and tissues between genetically unidentical individuals.
Key Properties: Polygeny and Extreme Polymorphism
Two fundamental genetic properties of the MHC ensure the immune system’s ability to cope with a vast array of constantly evolving pathogens: polygeny and polymorphism.
Polygeny means that the MHC locus contains several different genes that encode functionally distinct MHC molecules for both Class I and Class II. For example, in humans, the classical Class I molecules are encoded by the HLA-A, HLA-B, and HLA-C loci. Similarly, Class II molecules are encoded by HLA-DR, HLA-DP, and HLA-DQ loci. Since both sets of genes are co-expressed (codominance), a single individual typically expresses at least three different Class I and three to four different Class II molecules on their cells. This ensures that a single person can present a broad spectrum of different peptides, increasing the breadth of their immune defense.
Polymorphism refers to the existence of an unusually large number of different allelic variants for each MHC gene within the population as a whole. The MHC genes are, in fact, the most polymorphic genes known in the human genome, with thousands of different alleles for loci like HLA-B. This extreme variability ensures that it is highly unlikely for any two non-related individuals to have the exact same set of MHC molecules. While polygeny provides a wide range of binding specificity for one person, polymorphism provides the immune system of the entire species with an enormous collective defense capability against constantly mutating pathogens that attempt to evade immune detection.
MHC Class I: Intracellular Surveillance and Cytotoxic T Cells
MHC Class I molecules are expressed on the surface of virtually all nucleated cells and platelets in the body, serving as the system’s “internal security” signal. Their primary role is to present endogenous antigens, meaning antigens derived from proteins synthesized within the cell itself, such as viral proteins, self-proteins, or tumor antigens.
The structure of a classical MHC Class I molecule is a heterodimer composed of a heavy, polymorphic α-chain (encoded by the MHC genes) and a small, invariant protein called β2-microglobulin (encoded by a gene on a different chromosome). The α-chain consists of three extracellular domains (α1, α2, α3), with the α1 and α2 domains forming a closed peptide-binding groove. Due to these closed ends, the groove can only accommodate relatively short peptides, typically 8 to 10 amino acids in length, which are non-covalently bound and held in place by pockets on the floor of the groove.
The presentation pathway, known as the Cytosolic or Endogenous Pathway, involves the degradation of cytosolic proteins by the proteasome into small peptides. These peptides are then transported into the Endoplasmic Reticulum (ER) by the Transporters Associated with Antigen Processing (TAP). Inside the ER, the peptides are loaded onto newly synthesized MHC Class I molecules with the assistance of a complex that includes calreticulin and tapasin. The resulting MHC Class I-peptide complex is then transported to the cell surface, where it is recognized by CD8+ cytotoxic T lymphocytes (CTLs). When a CTL’s T-cell Receptor (TCR) binds to a foreign peptide presented by Class I, the CTL is activated to induce apoptosis (programmed cell death) in the infected or abnormal cell, effectively mediating cellular immunity against intracellular threats.
MHC Class II: Extracellular Threats and Helper T Cells
MHC Class II molecules have a restricted pattern of expression, found only on professional Antigen-Presenting Cells (APCs), which include B lymphocytes, macrophages, and dendritic cells. Their function is to present exogenous antigens, which are antigens derived from extracellular pathogens and proteins taken up from the outside environment via phagocytosis or endocytosis.
MHC Class II molecules are also heterodimers, composed of two similarly sized polypeptide chains: a heavy α chain and a lighter β chain, both encoded within the MHC Class II region. The α1 and β1 domains of the two chains combine to form the peptide-binding groove. Critically, the Class II groove has open ends, allowing it to accommodate longer peptides, typically 13 to 25 amino acids in length.
The presentation pathway, known as the Endosomal or Exogenous Pathway, begins when APCs internalize extracellular antigens and degrade them into peptides within acidic endosomal compartments. Simultaneously, MHC Class II molecules, synthesized in the ER, are prevented from binding endogenous peptides by an invariant chain. This MHC-invariant chain complex is transported to the endosomal compartment. Once there, the invariant chain is removed (leaving a small fragment called CLIP), and the MHC Class II molecule binds the degraded foreign peptide. The final complex is then transported to the cell surface, where it is presented to CD4+ helper T lymphocytes (T In addition to the classical Class I and Class II molecules, the MHC locus also contains genes for MHC Class III and nonclassical MHC molecules. MHC Class III genes encode for various immune-related proteins that are not directly involved in peptide presentation, such as components of the complement system (C2, C4) and certain inflammatory cytokines (e.g., Tumor Necrosis Factor). Nonclassical MHC Class IB genes encode for molecules that are structurally similar to Class I but exhibit limited polymorphism and distinct expression patterns, often induced by cellular stress to serve as ligands for immune cells like Natural Killer (NK) cells. The clinical significance of MHC molecules is profound and far-reaching. The high polymorphism of HLA genes is the biological basis for the immense challenge of organ transplantation, where MHC mismatches trigger the host’s immune system to launch a severe rejection response against the foreign tissue. Furthermore, specific MHC/HLA alleles are strongly associated with susceptibility or resistance to various autoimmune diseases (like Type 1 diabetes and rheumatoid arthritis) and infectious diseases, linking one’s genetic background directly to immune health. Lastly, understanding MHC pathways is central to modern cancer immunotherapy, as tumor cells often downregulate MHC Class I expression entirely to evade detection and destruction by CD8+ T cells, a mechanism scientists are now working to reverse.MHC Class III and Clinical Significance